Home › Funds › Point72 Asset Management › IBRX
Point72 Asset Management position in IBRX
IMMUNITYBIO INC · Health Care
Latest position (Q2 2026)132.00K sh
Reported value held$1.16M
Portfolio Weight0.00%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 106.34K | $193.54K | New |
| Q3 2023 | 15.50K | $26.20K | New |
| Q1 2026 | 160.10K | $1.23M | New |
| Q2 2026 | 132.00K | $1.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBRX
- BlackRock Inc 34.08M sh · $298.40M · Q2 2026
- D. E. Shaw & Co 11.55M sh · $101.13M · Q2 2026
- Two Sigma Investments 11.10M sh · $97.16M · Q2 2026
- Geode Capital Management 9.85M sh · $86.23M · Q2 2026
- Vanguard Group 32.78M sh · $64.90M · Q4 2025
- Citadel Advisors 5.67M sh · $49.68M · Q2 2026
- Millennium Management 5.58M sh · $48.85M · Q2 2026
- Northern Trust Corp 3.57M sh · $31.21M · Q2 2026
- Morgan Stanley 3.43M sh · $30.05M · Q2 2026
- Goldman Sachs Group 3.23M sh · $28.32M · Q2 2026
- UBS Group AG 3.20M sh · $27.98M · Q2 2026
- Charles Schwab Investment Management 2.89M sh · $25.29M · Q2 2026